In the ever-shifting landscape of healthcare investment banking, innovation isn't just a buzzword—it's the lifeline that keeps industries thriving. Bailey & Company is proving this with bold moves to expand its talented team, positioning itself for groundbreaking growth in emerging sectors. But here's where it gets intriguing: how might these changes reshape the way we think about specialized banking in healthcare? Stick around to uncover the details.
Bailey & Company, a leading independent investment bank dedicated to healthcare companies in the lower-middle and middle markets, has just unveiled an exciting team expansion. This includes two fresh hires and one well-deserved promotion, all designed to supercharge their expertise in core investment banking and propel them into new frontiers like medical technology and supply chain management. Imagine a firm that's already a powerhouse in healthcare services, healthcare technology, payer services, and pharma services/medtech/life sciences—now branching out even further to offer more tailored support to clients navigating these dynamic areas.
"For the past three years, we've poured resources into bolstering our operations, all to better serve our clients and spark fresh ideas that improve healthcare for everyone. These latest team additions mark another pivotal chapter in our journey," explained Tim Scallen, the company's chief executive officer.
Let's dive into the new faces making waves. Peter Machmeier comes on board as a managing director, with a sharp focus on medical devices and products, contract manufacturing, and medical equipment services. His background is impressive: before joining Bailey & Company, he held key investment banking positions at Kroll (previously known as Duff & Phelps) and Doughtery & Company. Most recently, he served as a managing director at Kroll, honing his skills in the medical technology and supply chain niches.
"Bailey & Company has really boosted its reputation in recent times, and I'm thrilled to join a thriving platform that's all about the healthcare space," Machmeier shared. "By incorporating medical technology and supply chain into their established strengths, Bailey & Company opens doors to serve both new and loyal clients in ways that truly matter. For beginners in the field, think of this as adding specialized tools to a toolbox—allowing for more precise, targeted advice in complex deals."
Then there's Brian Jones, who steps in as a director to bolster Bailey & Company's expanding pharma services and life sciences practices. He brings a rich mix of experience from healthcare services investment banking, management consulting, and even military service—offering a well-rounded perspective that's hard to match. Prior to this, he held senior roles at Jefferies and Harris Williams.
"I'm genuinely pumped to be part of Bailey & Company's vibrant, healthcare-centric investment banking scene," Jones said. "With over two decades of experience in healthcare mergers and acquisitions (M&A), plus cutting-edge research tools and a vast network of industry connections, the firm stands out as a go-to partner for founders and middle-market investors seeking reliable M&A guidance. This isn't just about transactions; it's about building lasting relationships that drive real-world impact, like helping startups scale into major players."
And for the promotion: Cray Yoo has been elevated to director, concentrating on healthcare IT & tech-enabled services and payer services. His diverse background includes investment banking, corporate strategy, and corporate development, drawn from stints at Kroll's healthcare investment banking team and corporate development at HMS, a leader in technology analytics and engagement solutions for healthcare payers.
"I'm overjoyed to contribute to Bailey & Company's ongoing expansion," Yoo remarked. "Having seen up close how our M&A advisory work delivers positive results for clients, I'm eager to team up with my colleagues and forge ahead into new ventures. For those new to this, M&A advisory is like matchmaking for businesses—ensuring the right partnerships form to create stronger, more innovative entities in healthcare."
"Bailey & Company has been on an upward trajectory for years," Scallen added. "The investments we've made over the last three years have empowered us to support clients better and drive innovations that enhance the healthcare system for all. These team enhancements are our next evolution, and I can't wait to witness Peter, Brian, and Cray's contributions as they dive into the industry and partner with our clients."
To put this growth into perspective, since 2023, Bailey & Company has steered over 30 investment banking deals and onboarded 20 skilled investment bankers. They've also produced 16 insightful research notes and reports since kicking off their market development initiatives in 2025, all while ramping up their visibility at nationwide healthcare conferences. This isn't just growth—it's a strategic play to stay ahead in a sector where adaptability can mean the difference between thriving and getting left behind.
But here's the part most people miss: In a world where independent banks like Bailey & Company are competing with giants, is this expansion a smart diversification or a risky overreach? And this is where it gets controversial—some might argue that focusing heavily on niche sectors could alienate broader clients, while others see it as a bold step toward genuine specialization. What do you think? Does this kind of targeted team-building strengthen the healthcare ecosystem, or does it limit opportunities in a broader market? We'd love to hear your take—agree, disagree, or share your own insights in the comments below!
About Bailey & Company
Bailey & Company, headquartered in Nashville, is a merchant banking powerhouse specializing in middle-market healthcare firms across healthcare services, healthcare technology, payer services, and pharma services/medtech/life sciences. As one of the nation's top independent, sector-dedicated investment banking and investing firms, they empower strong management teams with scalable solutions through expert strategic advice, top-tier guidance, and access to a diverse array of industry specialists. For more details, visit www.bnco.com.
More News From Bailey & Company
Back to Newsroom
